The New Zealand medical journal

Review of the realistic benefits and expectations of psilocybin for treating depression

Updated

Abstract

Early studies suggest psilocybin may help treat depression, but careful expectations are needed.

  • Psilocybin treatment shows promise for depression but may be influenced by expectation bias.
  • Some patients could experience side effects or even harm, which are often not well documented.
  • Research on ketamine for treatment-resistant depression presents similar issues but has stronger positive evidence.
  • The current evidence does not support broader use of psilocybin for depression treatment at this time.

Simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free